BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17332928)

  • 1. Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.
    Ishiyama S; Matsueda S; Jones LA; Efferson C; Celestino J; Schmandt R; Ioannides CG; Tsuda N; Chang DZ
    Int J Oncol; 2007 Apr; 30(4):889-98. PubMed ID: 17332928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
    Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
    Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between Numb and Notch in epithelial cancers: role for dual oxidase maturation factor.
    Ostrakhovitch EA
    Eur J Cancer; 2009 Aug; 45(12):2071-6. PubMed ID: 19523816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis.
    Pece S; Serresi M; Santolini E; Capra M; Hulleman E; Galimberti V; Zurrida S; Maisonneuve P; Viale G; Di Fiore PP
    J Cell Biol; 2004 Oct; 167(2):215-21. PubMed ID: 15492044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.
    Fiorini E; Merck E; Wilson A; Ferrero I; Jiang W; Koch U; Auderset F; Laurenti E; Tacchini-Cottier F; Pierres M; Radtke F; Luther SA; Macdonald HR
    J Immunol; 2009 Dec; 183(11):7212-22. PubMed ID: 19915064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of Notch signaling down-regulate Numb and Numblike.
    Chapman G; Liu L; Sahlgren C; Dahlqvist C; Lendahl U
    J Cell Biol; 2006 Nov; 175(4):535-40. PubMed ID: 17116748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling confers antigen-presenting cell functions on mast cells.
    Nakano N; Nishiyama C; Yagita H; Koyanagi A; Akiba H; Chiba S; Ogawa H; Okumura K
    J Allergy Clin Immunol; 2009 Jan; 123(1):74-81.e1. PubMed ID: 19130928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction.
    Kim SY; Yang D; Myeong J; Ha K; Kim SH; Park EJ; Kim IG; Cho NH; Lee KP; Jeon JH; So I
    Cell Calcium; 2013 Feb; 53(2):102-11. PubMed ID: 23140583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor.
    Li Y; Ishiyama S; Matsueda S; Tsuda N; Ioannides CG
    Oncol Rep; 2008 Jun; 19(6):1445-52. PubMed ID: 18497949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
    Asemissen AM; Haase D; Stevanovic S; Bauer S; Busse A; Thiel E; Rammensee HG; Keilholz U; Scheibenbogen C
    J Immunother; 2009 May; 32(4):370-5. PubMed ID: 19342968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
    Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2009 Jan; 200(1):75.e1-10. PubMed ID: 18976739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
    Wieckowski S; Baumgaertner P; Corthesy P; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Oct; 183(8):5397-406. PubMed ID: 19786555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain.
    McGill MA; McGlade CJ
    J Biol Chem; 2003 Jun; 278(25):23196-203. PubMed ID: 12682059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numb regulates Notch1, but not Notch3, during myogenesis.
    Beres BJ; George R; Lougher EJ; Barton M; Verrelli BC; McGlade CJ; Rawls JA; Wilson-Rawls J
    Mech Dev; 2011; 128(5-6):247-57. PubMed ID: 21356309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
    Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
    J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.